Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FMmeds vs Noom Med

FMmeds
Graded #261

Lower grade

vs+5.099999999999994
Noom Med
Graded #155

Higher grade

The verdict

Noom Med takes it — 68.3/100 to 63.2/100.

Noom Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Noom Med integrates GLP-1 medication access with Noom's proven cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and dedicated care team — the most comprehensive psychology-plus-medication…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNoom Med +43
46
89
Dose & formulationFMmeds +32
72
40
Clinical oversightNoom Med +7
70
77
Labs & monitoringNoom Med +10
53
63
FulfillmentFMmeds +24
97
73
Contract termsNoom Med +8
47
55
FMmeds · left barNoom Med · right bar

The numbers

MetricFMmedsNoom Med
WeighScore63.2/10068.3/100
GradeCC
Scorecard rank#261#155
Semaglutide$225/mo (all doses, compounded)Not disclosed
Tirzepatide$265/mo (all doses, compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
FMmeds

Graded #261 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Noom Med

Graded #155 · C

Strengths

  • Combines GLP-1 medication with CBT behavior change
  • Dedicated dietitian included in every plan
  • Highest support score in fitness app category
  • Integrated care team for medication and coaching
  • Noom's proven behavioral curriculum

Where it loses points

  • Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
  • More expensive than app-only alternatives
  • Requires commitment to both medication and coaching program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard